Predictors of Subcutaneous Injection Site Reactions to Sustained-Release Buprenorphine in Rhesus Macaques ()

Overview

Journal J Am Assoc Lab Anim Sci

Date 2021 Apr 28

PMID 33906705

Citations 3

Authors

Andrew J Haertel

Matthew A Schultz

Lois M Colgin

Amanda L Johnson

Affiliations

Soon will be listed here.

Abstract

Subcutaneous injection site reactions to sustained-release buprenorphine hydrochloride (Buprenorphine SR) in macaques have been reported in only a single case report. In the current study, we evaluated the incidence rate and predictors of buprenorphine SR reactions in the subcutaneous tissue of rhesus macaques (M) based on retrospective review of macaque buprenorphine SR injection records. Potentially predictive variables were identified with logistic regression modeling and were evaluated using model selection based on Akaike information criterion. Record review revealed sub- cutaneous tissue reactions occurred in 52 (3%) of 1559 injections and were noted between 4 and 311 d after injection. Model selection showed that body weight and MHC allele Mamu-B*29 were the best predictors of subcutaneous reactions. Based on these results, we recommend consideration of potential risk factors prior to the administration of buprenorphine SR to a rhesus macaque. In addition, the authors advise that using the highest concentration of buprenorphine SR available may reduce injection site reaction rates due to the injection of less copolymer.

Citing Articles

Pharmacokinetics of Extended-release Buprenorphine and Clinical Efficacy for Postoperative Pain Management in the Domestic Ferret ().

Plunkard J, Jimenez I, Tarwater P, Craney M, Villano J J Am Assoc Lab Anim Sci. 2024; .

PMID: 39164072 PMC: 11467869. DOI: 10.30802/AALAS-JAALAS-24-000011.

Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus).

Fabian N, Mannion A, Jamiel M, Anderson D, Rower J, Reilly C Sci Rep. 2023; 13(1):11864.

PMID: 37481609 PMC: 10363172. DOI: 10.1038/s41598-023-38973-2.

Long-Acting Opioid Analgesics for Acute Pain: Pharmacokinetic Evidence Reviewed.

Tyler B, Guarnieri M Vet Sci. 2023; 10(6).

PMID: 37368758 PMC: 10302878. DOI: 10.3390/vetsci10060372.

References

Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B . Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2015; 183(3):405-18. PMC: 4750591. DOI: 10.1111/cei.12739. View

Honess P, Gimpel J, Wolfensohn S, Mason G . Alopecia scoring: the quantitative assessment of hair loss in captive macaques. Altern Lab Anim. 2005; 33(3):193-206. DOI: 10.1177/026119290503300308. View

Summers L, Clingerman K, Yang X . Validation of a body condition scoring system in rhesus macaques (Macaca mulatta): assessment of body composition by using dual-energy X-ray absorptiometry. J Am Assoc Lab Anim Sci. 2012; 51(1):88-93. PMC: 3276972. View

Foley P, Liang H, Crichlow A . Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats. J Am Assoc Lab Anim Sci. 2011; 50(2):198-204. PMC: 3061420. View

Nunamaker E, Stolarik D, Ma J, Wilsey A, Jenkins G, Medina C . Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy. J Am Assoc Lab Anim Sci. 2014; 53(5):494-501. PMC: 4181691. View

Mackiewicz A, Salyards G, Knych H, Hill A, Christe K . Pharmacokinetics of a Long-lasting, Highly Concentrated Buprenorphine Solution after Subcutaneous Administration in Rhesus Macaques (). J Am Assoc Lab Anim Sci. 2019; 58(4):501-509. PMC: 6643088. DOI: 10.30802/AALAS-JAALAS-18-000115. View

Wiseman R, Karl J, Bimber B, OLeary C, Lank S, Tuscher J . Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med. 2009; 15(11):1322-6. PMC: 2824247. DOI: 10.1038/nm.2038. View

Horton R, Wilming L, Rand V, Lovering R, Bruford E, Khodiyar V . Gene map of the extended human MHC. Nat Rev Genet. 2004; 5(12):889-99. DOI: 10.1038/nrg1489. View

Yant L, Friedrich T, Johnson R, May G, Maness N, Enz A . The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol. 2006; 80(10):5074-7. PMC: 1472056. DOI: 10.1128/JVI.80.10.5074-5077.2006. View

10.

Kaizu M, Borchardt G, Glidden C, Fisk D, Loffredo J, Watkins D . Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics. 2007; 59(9):693-703. DOI: 10.1007/s00251-007-0233-7. View

11.

de Bakker P, Raychaudhuri S . Interrogating the major histocompatibility complex with high-throughput genomics. Hum Mol Genet. 2012; 21(R1):R29-36. PMC: 3459647. DOI: 10.1093/hmg/dds384. View

12.

Zhang X, Zhang C, Zhang W, Meng S, Liu D, Wang P . Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation. Drug Dev Ind Pharm. 2013; 41(2):342-52. DOI: 10.3109/03639045.2013.866140. View

13.

Thiede A, Garcia K, Stolarik D, Ma J, Jenkins G, Nunamaker E . Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica). J Am Assoc Lab Anim Sci. 2015; 53(6):692-9. PMC: 4253584. View

14.

Pichler W, Yawalkar N, Schmid S, Helbling A . Pathogenesis of drug-induced exanthems. Allergy. 2002; 57(10):884-93. DOI: 10.1034/j.1398-9995.2002.02161.x. View

15.

Molter C, Barbosa L, Johnson S, Knych H, Chinnadurai S, Wack R . Pharmacokinetics of a single subcutaneous dose of sustained release buprenorphine in northern elephant seals (Mirounga angustirostris). J Zoo Wildl Med. 2015; 46(1):52-61. DOI: 10.1638/2014-0115R.1. View

16.

Pichler W, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D . Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Med Clin North Am. 2010; 94(4):645-64, xv. DOI: 10.1016/j.mcna.2010.04.003. View

17.

den Dunnen W, Robinson P, van Wessel R, Pennings A, Van Leeuwen M, Schakenraad J . Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-epsilon-caprolactone). J Biomed Mater Res. 1997; 36(3):337-46. DOI: 10.1002/(sici)1097-4636(19970905)36:3<337::aid-jbm9>3.0.co;2-f. View

18.

Catbagan D, Quimby J, Mama K, Rychel J, Mich P . Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy. Am J Vet Res. 2011; 72(4):461-6. DOI: 10.2460/ajvr.72.4.461. View

19.

Ostrov D, Grant B, Pompeu Y, Sidney J, Harndahl M, Southwood S . Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A. 2012; 109(25):9959-64. PMC: 3382472. DOI: 10.1073/pnas.1207934109. View

20.

Bakker N, Van Erck M, Otting N, Lardy N, Noort R, t Hart B . Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region. J Exp Med. 1992; 175(4):933-7. PMC: 2119185. DOI: 10.1084/jem.175.4.933. View